Preclinical evaluation of the POLY-ADP ribose polymerase 1 (PARP-1) inhibitor AG014699 in combination with topotecan and temozolomide for the treatment of medulloblastoma and neuroblastoma

Professor Steven Clifford; Rachel Daniel; Agata Rozanska; Huw Thomas; Professor Alan Boddy; Professor Deborah Tweddle; Professor Nicola Curtin

Preclinical evaluation of the POLY-ADP ribose polymerase 1 (PARP-1) inhibitor AG014699 in combination with topotecan and temozolomide for the treatment of medulloblastoma and neuroblastoma Lookup NU author(s) Professor Steven Clifford Rachel Daniel Agata Rozanska Huw Thomas Professor Alan Boddy Professor Deborah Tweddle Professor Nicola Curtin



Author(s)		Clifford S, Daniel R, Rozanska A, Thomas HD, Boddy AV, Tweddle DA, Curtin NJ
Editor(s)
Publication type		Conference Proceedings (inc. Abstract)
Conference Name		39th International Conference of the International Society for Pediatric Oncology
Conference Location		National Centre for Performing Arts, Mumbai, India
Year of Conference		2007
Date		31-10-2007 - 03-11-2007
Volume		49
Pages		434-435 O.133
		1545-5009
ISBN




Full text for this publication is not currently held within this repository. Alternative links are provided below where available.



Publisher		Pediatric Blood and Cancer
URL		http://dx.doi.org/10.1002/pbc.21342
DOI		10.1002/pbc.21342

Actions
Library holdings		Search Newcastle University Library for this item